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Abstract
Memory T cells are composed of effector, central, and memory stem cells. Previous studies have implicated that both T-bet
and Eomes are involved in the generation of effector and central memory CD8 T cells. The exact role of these transcription
factors in shaping the memory T cell pool is not well understood, particularly with memory stem T cells. Here, we
demonstrate that both T-bet or Eomes are required for elimination of established tumors by adoptively transferred CD8 T
cells. We also examined the role of T-bet and Eomes in the generation of tumor-specific memory T cell subsets upon
adoptive transfer. We showed that combined T-bet and Eomes deficiency resulted in a severe reduction in the number of
effector/central memory T cells but an increase in the percentage of CD62LhighCD44low Sca-1+ T cells which were similar to
the phenotype of memory stem T cells. Despite preserving large numbers of phenotypic memory stem T cells, the lack of
both of T-bet and Eomes resulted in a profound defect in antitumor memory responses, suggesting T-bet and Eomes are
crucial for the antitumor function of these memory T cells. Our study establishes that T-bet and Eomes cooperate to
promote the phenotype of effector/central memory CD8 T cell versus that of memory stem like T cells.
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Introduction
Tumor growth can elicit type 1 cellular immune responses that
limit cancer progression. Ample clinical evidence shows that
longer survival of cancer patients is associated with increased
expression of genes characteristic of type 1 effector T cells, in
particular master transcription regulators T-bet and Eomes. [1–5]
In T cells, T-bet and Eomes are regulated by cytokines with
divergent functions and therefore have overlapping as well as
distinct functions [6–11]. IL-12 and IFN-c drive T-bet expression,
[12,13] and IL-2 promotes Eomes expression. [7,14,15] T-bet and
Eomes play an additive role in driving IFN-c production and
cytotoxic activities of effector CD8 T cells in vitro. [8,16] T-bet
and Eomes also coordinately promote T cell migration to inflamed
tissues by inducing chemokine receptors. [16,17] In addition, T-
bet and Eomes control the expression of CD122 and are required
for maintenance of IL-15-dependent memory CD8 T cells. [10,11]
High T-bet expression promotes short-lived effector CD8 T cells,
whereas low T-bet expression promotes long-lived memory cells.
[18], [6,11,19] Thus, T-bet and Eomes are important for both
function and homeostasis of effector and memory T cells.
However, the role of T-bet and Eomes in the setting of memory
T cell responses to tumor antigens is unknown.
The memory T cells have been typically divided into two main
subsets based on the expression of the lymph node homing
molecules CD62L and CCR7. [20] Central memory T cells (TCM)
express high levels of CD62L and CCR7, whereas effector
memory T cells (TEM) express low levels of CD62L and CCR7.
Recent studies demonstrated the existence of a new population of
memory T cells designated T memory stem cells (TSCM) [21] [22].
TSCM are CD44
low CD62Lhigh, a phenotype similar to those of
naı¨ve T cells [21]. Nevertheless, they differ from naı¨ve cells by
expressing stem cell antigen–1 (Sca-1) and proliferate vigorously
upon restimulation with its antigenic peptide [21] [23] [22].
Although T-bet and Eomes are known to be involved in both
function and homeostasis of effector and memory T cells, their role
in TSCM is not studied.
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Adoptive T cell therapy has become increasingly appreciated as
a feasible therapeutic approach for human cancer. The infused
tumor antigen-specific T cells are believed to adopt multiple
effector and memory T cell fates in the host. Since T-bet and
Eomes are master transcriptional factors for CD8 T cells, we
studied their individual and collective roles in determining the
phenotype and function of adoptively transferred T cells. We
demonstrated that T-bet and Eomes play a synergistic role during
the effector phase of an antitumor immunity. In addition, both T-
bet and Eomes are required for the maintenance of effector and
central memory CD8+ T cells. Interestingly, we found that the
absence of both T-bet and Eomes resulted in a T cell population
dominated by phenotypically-defined TSCM. Our study establishes
that the T-bet and Eomes transcriptional unit regulates the
balance between effector/central memory T cells and TSCM.
Methods
Mice
Generation of CD4-cre Eomes fl/fl (EKO) and T-bet2/2
CD4-cre Eomes fl/fl (DKO) mice has been described [16]. Pmel-1
TCR transgenic mice were purchased from the Jackson Labora-
tory and bred with TKO (the Jackson Laboratory), EKO, and
DKO mice. B6-LY5.2/Cr mice were purchased from Frederick
National Lab. All animal experiments have been approved by
IACUC of University of Pittsburgh and IACUC of Soochow
University.
Adoptive T cell Therapy
B6-LY5.2/Cr mice were challenged with 36105 B16F0 cells i.d.
6 days later, mice were irradiated at 500 rad. On day 7, the mice
were adoptively transferred with 56105 WT, T-bet2/2,
Eomes2/2, or T-bet/Eomes DKO pmel-1 T cells which have
been cultured in Th1 condition for 3 days. Tumor growth was
monitored every two days.
To examine the prophylactic function of adoptive transfer T
cells, B6-LY5.2/Cr mice were irradiated at 500 rad. 24 h post
irradiation, the mice were adoptively transferred with 46106 WT,
T-bet2/2, Eomes2/2, or T-bet/Eomes DKO pmel-1 T cells
which have been cultured in Th1 conditions for 4 days. 1 month
later, the recipient mice were challenged with 26105 B16F0 cells
i.d.
T Cell Culture
For generation of effector pmel-1 T cells, spleen and lymph
node were collected from C57BL/6 WT, TKO, EKO, and T/E
DKO pmel-1 TCR transgenic mice. CD8+ T cells were purified
using anti-CD8 magnetic beads (Miltenyi Biotech). Cells were
stimulated with irradiated T cell free APC, 1 mM mgp10025–33
(EGSRNQDWL), IL-2 (20 units/ml) and IL-12 (3.4 ng/ml) plus
anti–IL-4 (10 mg/ml, clone 11B11) for Tc1 for 72 h. APCs were
prepared from splenocytes that are depleted of T cells and
irradiated by 3000 rad.
Flow Cytometric Analysis
CD4 (clone GK1.5), CD8 (clone 53-6.7), CD44 (clone IM7),
CD122 (clone 5H4), CD62L (clone MEL-14), CD127 (clone
A7R34), CD45.1 (clone A20) and CD45.2. (clone 104) were
purchased from eBioscience (San Diego, CA). Flow cytometric
analysis was performed using a FACS flow cytometer (BD
Biosciences, San Jose, CA).
For intracellular cytokine staining, harvested cells were stimu-
lated with PMA (10 ng/ml) and ionomycin (1 mg/ml) for 4 h and
incubated for the last 1 h with brefeldin A (10 mg/ml). Cells were
subjected to intracellular cytokine analysis with anti–IL-17
(eBio17B7; eBioscience) and anti–IFN-c Ab (clone XMG1.2;
eBioscience).
Harvest of Tumor-infiltrating Lymphocytes
Tumor masses were removed, minced, and digested with
collagenase and hyaluronidase digestion solution (2.5 mg/ml
collagenase I, 1 mg/ml collagenase IV, 0.25 mg/ml hyaluronidase
IV-S, 300 mg/ml DNase I, and 0.01% HEPES in RPMI 1640
medium) at 37uC for 2 h. The pieces were then gently pressed
between the frosted edges of two sterile glass slides, and the cell
suspension was filtered through a 40-mm cell strainer (BD
Biosciences). Tumor-infiltrating lymphocytes (TILs) were further
purified by using the gradient as per manufacturer protocol,
washed, and re-suspended in HBSS for analysis.
Results
T-bet and Eomes are Required for Adoptive Tumor
Immunotherapy in Mice
Adoptive T cell therapy is a promising strategy for the treatment
of cancer. [24,25] To begin to dissect the genetic program
regulating the function of adoptively transferred T cells in tumor-
bearing hosts, we first focused on T-bet and Eomes.[1–5] To
generate tumor-reactive CD8+ T cells, we used T cells from WT,
T-bet2/2 (TKO), Eomes2/2 (EKO), and T-bet2/2
Eomes2/2 (DKO) pmel-1 T cell receptor transgenic mice. [26]
The number of naı¨ve pmel-1 T cells was comparable among all
strains. We stimulated pmel-1 naı¨ve T cells in vitro in Th1
conditions for three days to generate effector T cells specific for
melanoma antigen (Ag) gp100. At this time point, most of the T
cells had proliferated as determined by carboxyfluorescein
diacetate succinimidyl ester (CSFE) staining and there was no
difference in proliferation between the strains (data not shown),
consistent with our previous results and suggesting that T-bet and
Eomes were not required for clonal expansion of CD8 T cells [27].
In addition, the number of live cells was similar among WT,
TKO, EKO, and DKO pmel-1 T cells after 72 h in culture (data
not shown). We then infused the effector T cells to B16 melanoma-
bearing mice that had been non-lethally irradiated 24 h before.
Tumor growth was inhibited in recipient mice adoptively
transferred with WT pmel-1 T cells (Figure 1). Similarly, tumor
growth was inhibited in mice infused with either TKO or EKO
pmel-1 T cells, suggesting T-bet and Eomes were individually
non-essential (Figure 1). In contrast, adoptively transferring DKO
pmel-1 T cells failed to inhibit the tumor growth (Figure 1). These
data demonstrated that both T-bet and Eomes were required for
adoptive therapy of cancer.
T-bet and Eomes Control the Number, Trafficking and
Effector Function of Adoptively Transferred T cells
Since T-bet and Eomes are induced by different signals, [27] it
is conceivable that they might regulate different functions of the
adoptively transferred T cells in vivo. We first examined the
frequency of adoptively transferred pmel-1 T cells in secondary
lymphoid organs and tumor sites on approximately 20 days post
infusion. The purity of infused pmel-1 T cells were about 95%
CD8+ Vb13+ (data not shown), and CD44 was highly upregulated
in pmel-1 T cells regardless of their genotype (Figure S1 in file S1).
The donor T cells can be distinguished from endogenous T cells
by their distinctive CD45 alleles. We confirmed that majority of
CD45.2+ cells were CD8+Vb13+ upon infusion (Figure S2 file S1).
Thirty days after infusion, about 7% of the lymphocytes in the
spleen were donor CD45.2+ WT T cells (Figure 2 A and B).
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Similar percentages of infused T cells were found in mice receiving
TKO or EKO T cells (Figure 2 A and B). In contrast, only 1% of
donor DKO pmel-1 T cells could be detected at this time point
(Figure 2A), and this was statistically significant (Figure 2B). In
lymph nodes of the recipient mice, about 5% of the lymphocytes
were adoptively transferred WT T cells. Similar percentages of
EKO adoptively transferred T cells were observed in the lymph
node (Figure 2 A and C). In contrast, the percentage of adoptively
transferred TKO T cells was increased significantly to about 20%
in lymph nodes (Figure 2 A and C). Surprisingly, the percentage of
DKO T cells was similar to that of WT T cells in the lymph nodes
(Figure 2 A and C). These data suggest that T-bet and Eomes
might play different roles in the survival and trafficking of
adoptively transferred effector T cells in secondary lymphoid
organs.
The antitumor effect of adoptively transferred T cells is
ultimately determined by their ability to migrate to and carry
out effector functions within the tumor. We therefore examined
the frequency of the adoptively transferred pmel-1 T cells within
the B16 tumor. Approximately 30% of tumor infiltrating
lymphocytes (TIL) were WT pmel-1 T cells (Figure 2 A and D).
Either T-bet or Eomes deficiency resulted in a modest but
statistically significant reduction in the percentage of the donor T
cells among the TILs (Figure 2 A and D). Strikingly, T-bet and
Eomes double deficiency greatly reduced the number of donor T
cells in the tumor tissues (Figure 2 A and B). These data
demonstrated that T-bet and Eomes synergistically control T cell
persistence within the tumor. This is likely due to the combined
effect of lack of expression of chemokine receptors such as CXCR3
as we have reported in CD8 T cells previously [16], reduced
survival due to reduced CD122 [10], and diminished effector
function such as IFN-c production and cytolytic activities.
To further characterize adoptively transferred effector T cells,
we examined the surface markers such as CD44 and CD62L that
are characteristic of naı¨ve and memory T cell subsets. The
expression of CD44 and CD62L on the endogenous CD8 T cells
in spleens was not changed in all recipient mice regardless of the
genotype of the infused T cells (Figure 3A). Close to 100% of the
WT and EKO donor T cells were CD44high. About two thirds of
the WT and EKO CD44+ T cells were CD62Llow, characteristic
of effector cells, and one third were CD62Lhigh, typical of central
memory T cells. Therefore, the persistent WT and EKO T cells
consisted mainly of phenotypic central and effector memory T
cells. In contrast, the level of CD44 on the adoptively transferred
TKO T cells was modestly reduced (Figure 3 A and B). And a
population of CD62Lhigh CD44low T cells was evident (Figure 3A).
This phenotype is consistent with that of TSCM. [21] Similarly but
more dramatically, levels of CD44 on DKO T cells was more
significantly reduced (Figure 3 A and B). CD62Lhigh CD44low T
cells were prominently present in DKO pmel-1 T cells (Figure 3A).
In addition, the adoptive transferred T cells, regardless of their
genotypes, were all Sca-1high (Figure 3C). All activated T cells,
such as memory stem cells, memory and effector T cells, express
very high levels of Sca-1, whereas naı¨ve T cells express low levels
of Scal-1. The fact that DKO T cells bore naı¨ve characteristics
(CD62Lhigh CD44low) but also expressed high levels of Sca-1 was
Figure 1. Adoptive immune therapy in mice requires both T-bet and Eomes. B6-LY5.2/Cr mice were challenged with 36105 B16F0 cells i.d. 6
days later, mice were irradiated at 500 rad. On day 7, the mice were adoptively transferred with 56105 WT, T-bet2/2, Eomes2/2, or T-bet/Eomes
DKO pmel-1 T cells which have been cultured in Th1 condition for 3 days. Tumor growth was monitored every two days. 5 mice were in each group.
The no-transfer group did not receive any T cells. *P,0.05, determined by Mann-Whitney Test comparing recipients infused with DKO and WT T cells.
doi:10.1371/journal.pone.0067401.g001
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consistent with them being TSCM. These data suggest that T-bet
plays an important role in maintaining the effector/central
memory phenotype. The increase of CD62Lhigh CD44low popu-
lation was also consistent with our finding that more TKO T cells
were found in the lymph nodes (Figure 2C) because CD62L is
important for T cell trafficking to the lymph node. Eomes plays an
additional role in promoting effector T cell fate, as DKO T cells
had a greater decrease in CD44 levels (Figure 3B). Similar
decreases in the CD44high population within DKO T cells were
observed in lymph node cells (data not shown).
IFN-c production of adoptively transferred T cells was also
examined. About 85% of the donor WT T cells produced IFN-c
(Figure 3 D and E). The frequency of IFN-c+ cells modestly
reduced in EKO T cells (Figure 3 D and E). T-bet deletion
resulted in lower frequency of IFN-c producers (Figure 3 D and E).
The combined deficiency of T-bet and Eomes led to the greatest
reduction of the frequency of IFN-c producers. T-bet and Eomes
were shown to inhibit IL-17 production in CD8 T cells, and lack
of both T-bet and Eomes resulted in exacerbated inflammation in
a mouse infectious model. [28] However, although we observed a
great reduction of IFN-c producers, we did not find a significant
increase of IL-17-producing CD8 T cells within DKO T cells
(Figure 3 D). Thus, the increased tumor growth in mice infused
with DKO T cells was not due to alteration of IL-17 production.
T-bet and Eomes are Required for Maintaining Memory T
cells in the Blood and Secondary Lymphoid Organs
In order to examine the roles of T-bet and Eomes in memory T
cells, we infused in vitro-activated WT, TKO, EKO and DKO
effector T cells into non-lethally irradiated naı¨ve C57BL/6 mice.
We used pmel-1 TCR transgenic T cells, which provide TCR with
a strong affinity. This approach allowed tracking of defined
populations of antigen-specific memory CD8 cells and avoided the
interference of spontaneously generated memory phenotype cells
of unknown history. We have included IL-12 in the culture that
provided strong inflammatory signals. In addition, the recipient
mice had been non-lethally irradiated and conditioned for
Figure 2. T-bet and Eomes regulate tissue distribution and survival of the adoptive transferred T cells in tumor-bearing recipient
mice. B6-LY5.2/Cr mice were challenged with 36105 B16F0 cells i.d. 6 days later, mice were irradiated at 500 rad. On day 7, the mice were adoptively
transferred with 56105 WT, T-bet2/2, Eomes2/2, or T-bet/Eomes DKO pmel-1 T cells which have been cultured in Th1 condition for 3 days. (A)
Splenocytes (SPL), lymph node (LN) and tumor infiltrating lymphocytes (TILs) were harvested from tumor-bearing mice 20 days after T cell infusion.
The percentage of donor cells (CD45.2+) cells was determined by flow cytometry and the representative dot plots were shown. (B) The average
percentage of donor cells (CD45.2+) in spleen was shown (N = 4 for each genotype). (C) The average percentage of donor cells (CD45.2+) in lymph
nodes was shown (N = 4 for each genotype). (D) The average percentage of donor cells (CD45.2+) in tumor was shown (N = 4 for each genotype). Data
are presented as mean 6 SEM of four mice for each genotype. *P,0.05, **P,0.01 by Student’s t-test.
doi:10.1371/journal.pone.0067401.g002
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favorable homeostatic proliferation of the adoptively transferred T
cells. All measures ensured a productive generation of memory T
cells. [25,29] Regardless of genotypes, all of the in vitro activated
T cells expanded equivalently and were CD44high effector T cells
in vitro. These primed T cells were expected to become long-lived
memory T cells in vivo upon adoptive transfer. The recipient mice
were bled at different time points and the frequency of adoptively
transferred T cells was determined by flow cytometry. Three days
post adoptive transfer, the frequencies of transferred CD45.2+ T
cells in the blood were similar among mice receiving WT, TKO or
EKO donor T cells (Figure 4A). More than 90% of the CD45.2+
cells were CD8+Vb13+, confirming they were pmel-1 T cells (data
not shown). In contrast, the frequency of DKO T cells was
significantly lower (Figure 4A). The frequency of infused WT T
cells was reduced 15 and 29 days post transfer (Figure 4A). The
frequencies of TKO and EKO T cells were similarly reduced and
were not different from that of WT T cells. In contrast, the
frequency of DKO T cells was drastically reduced in the blood at
these time points in comparison to WT T cells (Figure 4A). From
day 29 to day 3 post infusion, there were about 4, 7, 6 and 1.5
folds reduction in the percentage of adoptive transferred T cells in
the blood for WT, TKO, EKO and DKO T cells respectively.
These data suggested that T-bet and Eomes were complementary
in determining the number of memory T cells in blood.
Thirty days post transfer, we analyzed the frequency of the
adoptively transferred T cells in secondary lymphoid organs.
Similar to what we observed in blood, there was no difference in
the frequency of memory T cells among the adoptively transferred
WT, TKO and EKO T cells in either spleens or lymph nodes.
There was about a two-fold and statistically significant reduction
of DKO memory T cells compared to WT memory T cells in both
spleens and lymph nodes (Figure 4B). The difference between
DKO and WT T cells in the blood was far greater than that in the
spleen or the in lymph node (Figure 4 A and B). Collectively these
Figure 3. T-bet and Eomes regulate the surface marker and function and adoptive transferred T cells in tumor-bearing mice. Pmel-1
T cells were adoptively transferred to tumor-bearing B6-LY5.2/Cr mice as in figure 1. 20 days post T cell infusion, spleen cells were harvested and
analyzed. (A) Dot plots show percentage of CD44hiCD62Lhi, CD44hiCD62Llo and CD44loCD62Lhi T cells in within donor (CD45.2+) and recipient
(CD45.22) CD8+ T cells. (B) The average percentage of donor cells (CD45.2+) CD44+ CD8+ T cells in the spleen was shown (N = 4 for each genotype). (C)
Sca-1 levels in the adoptive transferred CD8 T cells were shown. (D). Splenocytes were harvested from different recipient tumor-bearing mice, were
subsequently stimulated with PMA and ionomycin for 4 hours and incubated for the last 1 hour with brefeldin A. The percentage of donor pmel-1
CD8+ T cells producing IFN-c and IL-17 were examined. (E) The average percentage of IFN-c+ donor cells CD8+ T cells in the spleen as shown in (D) are
shown (N = 4 for each genotype). Data are presented as mean 6 SEM of four mice for each genotype. *P,0.05, ***P,0.001 by Student’s t-test.
doi:10.1371/journal.pone.0067401.g003
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data showed that T-bet and Eomes were important in maintaining
the memory pool and required for blood circulation of memory T
cells.
T-bet and Eomes were Required for Effector/central
Memory T cells but Dispensable for Phenotypic Memory
Stem T cells
Memory T cells have been divided into central and effector
memory T cells both of which are CD44high. Recently, another
subset of T cells called stem memory T cells have been discovered
which are CD44lowCD62Lhigh. [21,30] We showed that the level
of CD44 on fully activated effector DKO T cells was largely
equivalent to that of WT effector T cells after four-day culture
(Figure 5A). We examined the surface markers on these cells 30
days after infusion. Because recipient mice had been non-lethally
irradiated before T cell infusion, the donor T cells were expanded
in the lymphopenic hosts. IL-15 is shown to regulate memory T
cell proliferation and previous studies also demonstrated that
CD122, the receptor shared by IL-2 and IL-15, is regulated by T-
bet and Eomes in naı¨ve mice. [10] Consistent with published
results, CD122 expression was partially reduced in both TKO and
EKO T cells compared to WT T cells (Figure 5B). In contrast,
expression of CD122 was fully ablated in DKO T cells. More
strikingly, whereas 60% of the adoptively transferred WT, T-
bet2/2 and Eomes2/2 T cells were CD44high, less than 20% of
the DKO T cells were CD44high (Figure 5 B, C and D). In sharp
contrast, the percentage of CD44low memory cells was greatly
increased in DKO pmel-1 T cells compared with T cells of other
genotypes (Figure 5 B, C and D). Therefore T-bet and Eomes are
important for the survival of CD44high memory T cells, likely
mediated by CD122 signaling by IL-15. In contrast, they are not
required for CD44low phenotypic TSCM. The majority of the
CD44low cells were CD62Lhigh (Figure 5C), consistent with a
phenotype of TSCM. Sca-1 is considered as an important marker
for TSCM in mice [21,22]. We found that all infused T cells were
Sca-1high regardless of their genetic backgrounds (Figure 5E).
These data suggest that DKO memory T cells had features of
TSCM. In addition, DKO T cells expressed high similar levels of
bcl-2 compared to WT, EKO and TKO T cells. We then
examined the ability of the memory T cells to produce IFN-c. The
frequencies of IFN-c-producers were similar between WT and
EKO memory T cells. In contrast, the frequency of IFN-c+ cells
was significantly reduced in TKO T cells (Figure 5 F). The
frequency of IFN-c+ cells was further reduced in DKO T cells
(Figure 5 F). These data suggest that T-bet and Eomes all
contribute to the immediate effector function of memory T cells, as
measured by IFN-c production. In contrast, similar percentages of
adoptively transferred T cells, regardless of their genotypes, made
IL-2 (figure 5G). Although CXCR3 was shown expressed in
human TSCM, [30] it was not expressed on adoptively transferred
DKO T cells (data not shown), consistent with our previously
published data. [16].
T-bet and Eomes were Required for the Antitumor Recall
Responses Mediated by Adoptively Transferred T cells
Our data suggest that, despite the drastic reduction of memory
T cells in the blood, the total number of memory DKO T cells in
the lymph node and spleen was about two-fold reduced compared
to WT T cells. The numbers of memory TKO and EKO T cells
Figure 4. T-bet and Eomes regulate T cell numbers in blood upon adoptive transfer into non-lethally irradiated mice. B6-LY5.2/Cr
mice were irradiated at 500 rad. 24 h post irradiation, the mice were adoptively transferred with 56105 WT, T-bet2/2, Eomes2/2, or T-bet/Eomes
DKO pmel-1 T cells which have been cultured in the Th1 condition for 4 days. (A) The recipient mice were bled at different time points and the
frequency of the adoptively transferred T cells (CD45.2) among total CD45+ cells (CD45.2 plus CD45.1) was determined by flow cytometry. (B) The
frequency of the adoptively transferred T cells in spleen and LN were analyzed 30 days post transfer. Data are presented as mean 6 SEM of five mice
for each genotype. ***P,0.001 by Student’s t-test.
doi:10.1371/journal.pone.0067401.g004
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were similar to that of WT T cells. However, it was not clear
whether TKO, EKO or DKO memory T cells were functionally
competent. To address this question, we re-challenged recipients
with B16 tumor cells and monitored tumor growth (Figure 6 A).
The mice infused with WT pmel-1 T cells were fully protected
from a second inoculation of tumor cells. Similarly, all mice
receiving TKO or EKO pmel-1 T cells were protected from tumor
growth (Figure 6 B). In contrast, mice receiving DKO T cells
succumbed to the challenge with B16 cells and grew tumor
(Figure 6 B). These results suggest that T-bet and Eomes are
complementary or redundant in carrying out recall immune
responses against tumor.
We then examined whether WT, TKO, EKO, and DKO
memory T cells exhibited different proliferative potentials. We re-
stimulated the memory T cells from spleens of the recipient mice
with 0.01 mM gp10025–33 peptide for 72 h in vitro. As expected,
host CD8 T cells did not enlarge in size or proliferated (Figure 6C).
Without addition of the gp10025–33 peptide, the donor T cells also
did not proliferate (data not shown). In contrast, the donor WT
pmel-1 T cells blasted and proliferated vigorously upon stimula-
tion with the gp10025–33 peptide (Figure 6C). This assay also
showed no difference in the proliferation potential in recall
responses among WT, TKO, EKO, and DKO pmel-1 memory T
cells (Figure 6 C). Similar results were obtained with splenocytes
stimulated with higher concentrations of gp10025–33 peptide
(0.1 mM and 1 mM) or with lymph node cells (data not shown).
Collectively, these data suggest the effector functions rather than
the proliferative potential are controlled by T-bet and Eomes in
memory T cells. These results also demonstrated that DKO peml-
1 memory T cells were capable of hyper-proliferation upon recall
stimulation, even with very low amounts of antigen, consistent
with a phenotype of TSCM. In addition to proliferation, CD44
Figure 5. T-bet and Eomes regulate memory subsets of the adoptive transferred T cells. (A) WT, T-bet2/2 (TKO), Eomes2/2 (EKO), or T-
bet/Eomes DKO pmel-1 T cells were cultured in Th1 conditions for 4 days. Expression of CD44 and CD62L on pmel-1 T cells was examined by flow
cytometry. (B) B6-LY5.2/Cr mice (CD45.1) were adoptively transferred with WT, T-bet2/2, Eomes2/2, or T-bet/Eomes DKO pmel-1 T cells (CD45.2).
Blood was collected from different recipient mice and stained for CD45.2, CD8, CD44, CD122 30 days after transfer. (C) Thirty days post transfer,
spleens and lymph nodes (LN) were harvested. Surface markers CD44 and CD62L were examined by flow cytometry. Host cells were CD8+CD45.1+.
WT, TKO, EKO, and DKO indicate representative plots of CD44 versus CD62L of CD8+CD4.5.2+ donor CD8 T cells. (D) Thirty days post transfer, spleens
were harvested. The average percentage of donor cells (CD45.2+) CD44+ CD8+ T cells among all the donor CD8+ T cells in the spleen was shown (N = 5
for each genotype). (E) Thirty days post transfer, spleens were harvested. Sca-1 expression on donor CD45.2+ CD8+ T cells was shown (representative
of five independent experiments). (F) and (G) Splenocytes were then stimulated with PMA and ionomycin for 4 hours and incubated for the last 1
hour with Brefeldin A. CD45.2+ Cells producing IFN-c (F) and IL-2 (G) were examined with intracellular cytokine staining and flow cytometry. The
average percentages of IFN-c+ and IL-2+ cells among the donor CD45.2+ CD8+ T cells in the spleen were shown (N = 5 for each genotype). Data are
presented as mean 6 SEM of five samples for each genotype. ***P,0.001 by Student’s t-test.
doi:10.1371/journal.pone.0067401.g005
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could be up-regulated in DKO T cells (figure S3 in file S1),
suggesting DKO T cells were capable of some levels of
differentiate.
Discussion
In this study, we examined the role of T-bet and Eomes in both
effector and memory responses against tumor. In the setting of
adoptive immune therapy of an existing tumor, we showed that
the lack of either T-bet or Eomes did not significantly compromise
the antitumor effect. However, ‘‘knockout’’ of both of these
transcription factors rendered the therapy ineffective. In order to
study how T-bet and Eomes regulate the memory T cell pool, we
infused T cells of single or double T-bet and Eomes deletion into
non-lethally irradiated mice and characterized these T cells and
the antitumor recall response. We found that deletion of both T-
bet and Eomes in CD8 T cells profoundly inhibited the persistence
of effector and central memory T cells. To our surprise, despite the
depletion of bulk central and effector memory T cells, the total
number of memory DKO T cells was about half of WT T cells in
secondary lymphoid organs. Further analysis revealed that
deletion of T-bet and Eomes led to a significant increase in the
proportion of tumor antigen-specific phenotypic memory stem T
cells. These data suggest that T-bet and Eomes are important for
differentiation and maintenance of central and effector memory
cells, but non-essential or suppressive for generation and
persistence of stem cell like memory CD8 T cells (Figure 7).
One interesting outcome of this study is that the DKO memory
cells bore characteristics consistent with the phenotype of TSCM.
[21,22] The predominant feature of TSCM is CD44
low CD62Lhi
Sca-1+. We found majority of DKO memory T cells were indeed
CD44low CD62Lhi Sca-1+. We have also found that before
adoptive transfer, all the cells have proliferated and therefore were
post-mitotic, fitting another important feature of TSCM. [21] In
addition, recall response assays showed that DKO memory T cells
proliferated similarly upon recall stimulation even with very low
antigen. So the recall clonal expansion was normal for DKO
memory T cells. Collectively, these data showed that the majority
of DKO memory T cells were likely TSCM.
Recent studies have firmly established that TSCM have potent
antitumor activities upon infusion into host mice [22]. In contrast,
DKO T cells, which were phenotypically similar to TSCM, were
severely compromised in their antitumor function. However these
results are not conflicting. We believe the antitumor effect of
memory stem cells is dependent on further differentiation of
memory stem cells into effector cells in vivo and such differenti-
Figure 6. T-bet and Eomes are required for the memory recall responses against tumor cell rechallenge. (A) B6-LY5.2/Cr mice were non-
lethally irradiated at 500 rad, within 24 hours of irradiation, mice were adoptively transferred with 46106 WT, T-bet2/2, Eomes2/2, or T-bet/Eomes
DKO pmel-1 T cells which have been cultured in Th1 condition for 4 days. One month later, mice were challenged with 26105 B16F0 cells i.d. (B)
Tumor growth was monitored every other day. 5 mice were in each group. ***P,0.001, determined by Mann-Whitney Test comparing recipients with
DKO and WT T cells. (C) Thirty days post T cell infusion, spleens were harvested. Splenocytes were stained with CFSE and then stimulated with
0.01 mM gp10025–33 peptide for 72 h hours. Then the donor cells (CD45.2+CD8+) were analyzed by flow cytometry for CFSE dilution. Host CD8 T cells
were the CD45.1+ CD8+ population. Data are representative of three independent experiments.
doi:10.1371/journal.pone.0067401.g006
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ation program is dependent on T-bet and Eomes. Although
memory stem cells share many properties with central memory T
cells, they are thought to be distinctive in terms of developmental
stage. Central memory T cells are more differentiated because
they express T cell lineage transcription factors such as T-bet and
Eomes. In contrast, TSCM are pluripotent and can further
differentiate into effector and memory cells. Therefore, the T cell
activation program not only results in the generation of effector
and central memory T cells with a determined function, but also
result in clonal expansion of pluripotent memory stem T cells.
Asymmetric cell division is a mechanism that allows both self-
renewal and differentiation of stem cells, resulting the production
of one stem cell and one differentiating cell. A recent study
showing asymmetric segregation of T-bet into two daughter cells
after T cell division supports a role of T-bet in dichotomy between
differentiated and stem T cells [31]. The benefit of memory stem
cells is likely to select and expand T cells with specific activities
while preserving their differentiation potential to become effector
cells and central memory T cells by taking further inflammatory
cues. Our data suggest that T-bet and Eomes regulate the balance
between the ‘‘stemness’’ and differentiation of memory T cells
(Figure 7).
Supporting Information
File S1
(PDF)
Acknowledgments
The authors thank Drs. Lisa Borghesi, Penny Morel, Sarah Gaffen and
Zhaoyang You for critical reading of this manuscript.
Author Contributions
Conceived and designed the experiments: XC XZ BL. Performed the
experiments: GL QY YZ HW. Analyzed the data: QY BL. Contributed
reagents/materials/analysis tools: HW BL XZ XC. Wrote the paper: GL
QY BL.
References
1. Pages F, Berger A, Camus M, Sanchez-Cabo F, Costes A, et al. (2005) Effector
memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med
353: 2654–2666.
2. Chen LJ, Zheng X, Shen YP, Zhu YB, Li Q, et al. (2012) Higher numbers of T-
bet(+) intratumoral lymphoid cells correlate with better survival in gastric cancer.
Cancer Immunol Immunother.
3. Chen LJ, Sun J, Wu HY, Zhou SM, Tan Y, et al. (2011) B7-H4 expression
associates with cancer progression and predicts patient’s survival in human
esophageal squamous cell carcinoma. Cancer Immunol Immunother 60: 1047–
1055.
4. Lu B, Chen L, Liu L, Zhu Y, Wu C, et al. (2011) T-cell-mediated tumor immune
surveillance and expression of B7 co-inhibitory molecules in cancers of the upper
gastrointestinal tract. Immunol Res 50: 269–275.
5. Atreya I, Schimanski CC, Becker C, Wirtz S, Dornhoff H, et al. (2007) The T-
box transcription factor eomesodermin controls CD8 T cell activity and lymph
node metastasis in human colorectal cancer. Gut 56: 1572–1578.
6. Takemoto N, Intlekofer AM, Northrup JT, Wherry EJ, Reiner SL (2006)
Cutting Edge: IL-12 inversely regulates T-bet and eomesodermin expression
during pathogen-induced CD8+ T cell differentiation. J Immunol 177: 7515–
7519.
7. Qui HZ, Hagymasi AT, Bandyopadhyay S, St Rose MC, Ramanarasimhaiah R,
et al. (2011) CD134 plus CD137 dual costimulation induces Eomesodermin in
CD4 T cells to program cytotoxic Th1 differentiation. J Immunol 187: 3555–
3564.
8. Pearce EL, Mullen AC, Martins GA, Krawczyk CM, Hutchins AS, et al. (2003)
Control of effector CD8+ T cell function by the transcription factor
Eomesodermin. Science 302: 1041–1043.
9. Paley MA, Kroy DC, Odorizzi PM, Johnnidis JB, Dolfi DV, et al. (2012)
Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic
viral infection. Science 338: 1220–1225. doi: 1210.1126/science.1229620.
10. Intlekofer AM, Takemoto N, Wherry EJ, Longworth SA, Northrup JT, et al.
(2005) Effector and memory CD8+ T cell fate coupled by T-bet and
eomesodermin. Nat Immunol 6: 1236–1244.
11. Banerjee A, Gordon SM, Intlekofer AM, Paley MA, Mooney EC, et al. (2010)
Cutting edge: The transcription factor eomesodermin enables CD8+ T cells to
compete for the memory cell niche. J Immunol 185: 4988–4992.
12. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, et al. (2000) A novel
transcription factor, T-bet, directs Th1 lineage commitment. Cell 100: 655–669.
13. Mullen AC, High FA, Hutchins AS, Lee HW, Villarino AV, et al. (2001) Role of
T-bet in commitment of TH1 cells before IL-12-dependent selection. Science
292: 1907–1910.
14. Pipkin ME, Sacks JA, Cruz-Guilloty F, Lichtenheld MG, Bevan MJ, et al. (2010)
Interleukin-2 and inflammation induce distinct transcriptional programs that
promote the differentiation of effector cytolytic T cells. Immunity 32: 79–90.
15. Hinrichs CS, Spolski R, Paulos CM, Gattinoni L, Kerstann KW, et al. (2008) IL-
2 and IL-21 confer opposing differentiation programs to CD8+ T cells for
adoptive immunotherapy. Blood 111: 5326–5333.
16. Zhu Y, Ju S, Chen E, Dai S, Li C, et al. (2010) T-bet and eomesodermin are
required for T cell-mediated antitumor immune responses. J Immunol 185:
3174–3183.
17. Lord GM, Rao RM, Choe H, Sullivan BM, Lichtman AH, et al. (2005) T-bet is
required for optimal proinflammatory CD4+ T-cell trafficking. Blood 106:
3432–3439.
18. Joshi NS, Cui W, Chandele A, Lee HK, Urso DR, et al. (2007) Inflammation
directs memory precursor and short-lived effector CD8(+) T cell fates via the
graded expression of T-bet transcription factor. Immunity 27: 281–295.
19. Intlekofer AM, Takemoto N, Kao C, Banerjee A, Schambach F, et al. (2007)
Requirement for T-bet in the aberrant differentiation of unhelped memory
CD8+ T cells. J Exp Med 204: 2015–2021.
20. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A (1999) Two subsets of
memory T lymphocytes with distinct homing potentials and effector functions.
Nature 401: 708–712.
Figure 7. T-bet and Eomes determine memory T cell subsets.
Upon activation, naı¨ve T cells are destined to different cellular fates.
Current data show that T-bet and Eomes are crucial for the generation
of various effector, memory and exhausted T cell subsets. Higher levels
of T-bet drive terminally differentiated effector T cells which eventually
either become exhausted by further up-regulating Eomes or undergo
apoptosis. T cell expressing lower levels of T-bet become memory T
cells which also express Eomes. Activated naı¨ve T cells can also take a
fate of becoming TSCM, which maintain their ‘‘naivety’’ and develop-
mental potential. Our data suggest that T-bet and Eomes regulate the
balance between TEM, TCM, and TSCM.
doi:10.1371/journal.pone.0067401.g007
T-Bet and Eomes Balance Memory T Cell Subsets
PLOS ONE | www.plosone.org 9 June 2013 | Volume 8 | Issue 6 | e67401
21. Zhang Y, Joe G, Hexner E, Zhu J, Emerson SG (2005) Host-reactive CD8+
memory stem cells in graft-versus-host disease. Nat Med 11: 1299–1305.
22. Gattinoni L, Zhong XS, Palmer DC, Ji Y, Hinrichs CS, et al. (2009) Wnt
signaling arrests effector T cell differentiation and generates CD8+ memory stem
cells. Nat Med 15: 808–813.
23. Kato K, Cui S, Kuick R, Mineishi S, Hexner E, et al. (2010) Identification of
stem cell transcriptional programs normally expressed in embryonic and neural
stem cells in alloreactive CD8+ T cells mediating graft-versus-host disease. Biol
Blood Marrow Transplant 16: 751–771.
24. Lizee G, Overwijk WW, Radvanyi L, Gao J, Sharma P, et al. (2012) Harnessing
the Power of the Immune System to Target Cancer. Annu Rev Med.
25. Restifo NP, Dudley ME, Rosenberg SA (2012) Adoptive immunotherapy for
cancer: harnessing the T cell response. Nat Rev Immunol 12: 269–281.
26. Overwijk WW, Theoret MR, Finkelstein SE, Surman DR, de Jong LA, et al.
(2003) Tumor regression and autoimmunity after reversal of a functionally
tolerant state of self-reactive CD8+ T cells. J Exp Med 198: 569–580.
27. Zhou X, Yu S, Zhao DM, Harty JT, Badovinac VP, et al. (2010) Differentiation
and persistence of memory CD8(+) T cells depend on T cell factor 1. Immunity
33: 229–240.
28. Intlekofer AM, Banerjee A, Takemoto N, Gordon SM, Dejong CS, et al. (2008)
Anomalous type 17 response to viral infection by CD8+ T cells lacking T-bet
and eomesodermin. Science 321: 408–411.
29. Wiesel M, Oxenius A (2012) From crucial to negligible: functional CD8(+) T-cell
responses and their dependence on CD4(+) T-cell help. Eur J Immunol 42:
1080–1088.
30. Gattinoni L, Lugli E, Ji Y, Pos Z, Paulos CM, et al. (2011) A human memory T
cell subset with stem cell-like properties. Nat Med 17: 1290–1297.
31. Chang JT, Ciocca ML, Kinjyo I, Palanivel VR, McClurkin CE, et al. (2011)
Asymmetric proteasome segregation as a mechanism for unequal partitioning of
the transcription factor T-bet during T lymphocyte division. Immunity 34: 492–
504.
T-Bet and Eomes Balance Memory T Cell Subsets
PLOS ONE | www.plosone.org 10 June 2013 | Volume 8 | Issue 6 | e67401
